Related references
Note: Only part of the references are listed.Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia
Kanti R. Rai
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
An Anti-B Cell Maturation Antigen Bispecific Antibody for Multiple Myeloma
Nitya S. Ramadoss et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
Yu-Tzu Tai et al.
BLOOD (2014)
The impact of intra-clonal heterogeneity on the treatment of multiple myeloma
Annamaria Brioli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
Robert O. Carpenter et al.
CLINICAL CANCER RESEARCH (2013)
CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
Andre Veillette et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule
Antonella Chillemi et al.
MOLECULAR MEDICINE (2013)
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival
Eric Sanchez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Monoclonal antibody-based immunotherapy for multiple myeloma
Ivetta Danylesko et al.
IMMUNOTHERAPY (2012)
Homing and Adhesion Patterns Determine the Cellular Composition of the Bone Marrow Plasma Cell Niche
Elodie Belnoue et al.
JOURNAL OF IMMUNOLOGY (2012)
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S. K. Kumar et al.
LEUKEMIA (2012)
APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status
John Quinn et al.
BLOOD (2011)
Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow
Thomas Matthes et al.
BLOOD (2011)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown
Fan-Ru Lin et al.
CANCER RESEARCH (2007)
Antibody targeting of B-cell maturation antigen on malignant plasma cells
Maureen C. Ryan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
BAFF, APRIL and their receptors: Structure, function and signaling
Claudia Bossen et al.
SEMINARS IN IMMUNOLOGY (2006)
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: Effects of linker technology on efficacy and toxicity
SO Doronina et al.
BIOCONJUGATE CHEMISTRY (2006)
PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage
G Cattoretti et al.
JOURNAL OF PATHOLOGY (2005)
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
J Moreaux et al.
BLOOD (2004)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)